<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37373377</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>29</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>12</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>16</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Antioxidant Genetic Variants Modify Echocardiography Indices in Long COVID.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">10234</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms241210234</ELocationID><Abstract><AbstractText>Although disturbance of redox homeostasis might be responsible for COVID-19 cardiac complications, this molecular mechanism has not been addressed yet. We have proposed modifying the effects of antioxidant proteins polymorphisms (superoxide dismutase 2 (<i>SOD2</i>), glutathione peroxidase 1 (<i>GPX1</i>), glutathione peroxidase 3 (<i>GPX3</i>) and nuclear factor erythroid 2-related factor 2, (<i>Nrf2</i>)) in individual susceptibility towards the development of cardiac manifestations of long COVID-19. The presence of subclinical cardiac dysfunction was assessed via echocardiography and cardiac magnetic resonance imaging in 174 convalescent COVID-19 patients. SOD2, <i>GPX1</i>, <i>GPX3</i> and <i>Nrf2</i> polymorphisms were determined via the appropriate PCR methods. No significant association of the investigated polymorphisms with the risk of arrhythmia development was found. However, the carriers of variant <i>GPX1</i>*T, <i>GPX3</i>*C or <i>Nrf2</i>*A alleles were more than twice less prone for dyspnea development in comparison with the carriers of the referent ones. These findings were even more potentiated in the carriers of any two variant alleles of these genes (OR = 0.273, and <i>p</i> = 0.016). The variant <i>GPX</i> alleles were significantly associated with left atrial and right ventricular echocardiographic parameters, specifically LAVI, RFAC and RV-EF (<i>p</i> = 0.025, <i>p</i> = 0.009, and <i>p</i> = 0.007, respectively). Based on the relation between the variant <i>SOD2</i>*T allele and higher levels of LV echocardiographic parameters, EDD, LVMI and GLS, as well as troponin T (<i>p</i> = 0.038), it can be proposed that recovered COVID-19 patients, who are the carriers of this genetic variant, might have subtle left ventricular systolic dysfunction. No significant association between the investigated polymorphisms and cardiac disfunction was observed when cardiac magnetic resonance imaging was performed. Our results on the association between antioxidant genetic variants and long COVID cardiological manifestations highlight the involvement of genetic propensity in both acute and long COVID clinical manifestations.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Asanin</LastName><ForeName>Milika</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinic of Cardiology, Clinical Centre of Serbia, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ercegovac</LastName><ForeName>Marko</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinic of Neurology, Clinical Centre of Serbia, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krljanac</LastName><ForeName>Gordana</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinic of Cardiology, Clinical Centre of Serbia, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Djukic</LastName><ForeName>Tatjana</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-1959-5115</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical and Clinical Biochemistry, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coric</LastName><ForeName>Vesna</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0003-0227-821X</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical and Clinical Biochemistry, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jerotic</LastName><ForeName>Djurdja</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical and Clinical Biochemistry, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pljesa-Ercegovac</LastName><ForeName>Marija</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8969-0594</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical and Clinical Biochemistry, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matic</LastName><ForeName>Marija</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical and Clinical Biochemistry, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Milosevic</LastName><ForeName>Ivana</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-4331-3328</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinic of Infectious and Tropical Diseases, Clinical Centre of Serbia, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viduljevic</LastName><ForeName>Mihajlo</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-3470-7990</Identifier><AffiliationInfo><Affiliation>Clinic of Cardiology, Clinical Centre of Serbia, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stevanovic</LastName><ForeName>Goran</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinic of Infectious and Tropical Diseases, Clinical Centre of Serbia, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ranin</LastName><ForeName>Jovan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-0398-9486</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinic of Infectious and Tropical Diseases, Clinical Centre of Serbia, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simic</LastName><ForeName>Tatjana</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-8683-5129</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical and Clinical Biochemistry, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Sciences, Serbian Academy of Sciences and Arts, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bukumiric</LastName><ForeName>Zoran</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-7609-4504</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Statistics and Informatics, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Savic-Radojevic</LastName><ForeName>Ana</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-2026-4180</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical and Clinical Biochemistry, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Project No. 7546803</GrantID><Agency>Special Research Program on COVID-19, entitled AntioxIdentification, Science Fund of the Republic of Serbia.</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000975">Antioxidants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051267">NF-E2-Related Factor 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.11.1.9</RegistryNumber><NameOfSubstance UI="D005979">Glutathione Peroxidase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.11.1.9</RegistryNumber><NameOfSubstance UI="D000094765">Glutathione Peroxidase GPX1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000975" MajorTopicYN="Y">Antioxidants</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051267" MajorTopicYN="N">NF-E2-Related Factor 2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005979" MajorTopicYN="N">Glutathione Peroxidase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094765" MajorTopicYN="N">Glutathione Peroxidase GPX1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004452" MajorTopicYN="N">Echocardiography</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">GPX1</Keyword><Keyword MajorTopicYN="N">GPX3</Keyword><Keyword MajorTopicYN="N">Nrf2</Keyword><Keyword MajorTopicYN="N">SOD2</Keyword><Keyword MajorTopicYN="N">antioxidant genetic variants</Keyword><Keyword MajorTopicYN="N">cardiological manifestations</Keyword><Keyword MajorTopicYN="N">long COVID-19</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>29</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>28</Day><Hour>1</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37373377</ArticleId><ArticleId IdType="pmc">PMC10299268</ArticleId><ArticleId IdType="doi">10.3390/ijms241210234</ArticleId><ArticleId IdType="pii">ijms241210234</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Basso C., Leone O., Rizzo S., De Gaspari M., Van Der Wal A.C., Aubry M.-C., Bois M.C., Lin P.T., Maleszewski J.J., Stone J.R. Pathological features of COVID-19-associated myocardial injury: A multicentre cardiovascular pathology study. Eur. Heart J. 2020;41:3827&#x2013;3835. doi: 10.1093/eurheartj/ehaa664.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa664</ArticleId><ArticleId IdType="pmc">PMC7543528</ArticleId><ArticleId IdType="pubmed">32968776</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuck K.H. Arrhythmias and sudden cardiac death in the COVID-19 pandemic. Herz. 2020;45:325&#x2013;326. doi: 10.1007/s00059-020-04924-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00059-020-04924-0</ArticleId><ArticleId IdType="pmc">PMC7181098</ArticleId><ArticleId IdType="pubmed">32333026</ArticleId></ArticleIdList></Reference><Reference><Citation>Patone M., Mei X.W., Handunnetthi L., Dixon S., Zaccardi F., Shankar-Hari M., Watkinson P., Khunti K., Harnden A., Coupland C.A.C., et al. Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nat. Med. 2022;28:410&#x2013;422. doi: 10.1038/s41591-021-01630-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01630-0</ArticleId><ArticleId IdType="pmc">PMC8863574</ArticleId><ArticleId IdType="pubmed">34907393</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatla A., Mayer M.M., Adusumalli S., Hyman M.C., Oh E., Tierney A., Moss J., Chahal A.A., Anesi G., Denduluri S., et al. COVID-19 and cardiac arrhythmias. Heart Rhythm. 2020;17:1439&#x2013;1444. doi: 10.1016/j.hrthm.2020.06.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2020.06.016</ArticleId><ArticleId IdType="pmc">PMC7307518</ArticleId><ArticleId IdType="pubmed">32585191</ArticleId></ArticleIdList></Reference><Reference><Citation>Muhamad S.A., Ugusman A., Kumar J., Skiba D., Hamid A.A., Aminuddin A. COVID-19 and Hypertension: The What, the Why, and the How. Front. Physiol. 2021;12:665064. doi: 10.3389/fphys.2021.665064.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2021.665064</ArticleId><ArticleId IdType="pmc">PMC8126692</ArticleId><ArticleId IdType="pubmed">34012410</ArticleId></ArticleIdList></Reference><Reference><Citation>Argenziano M.G., Bruce S.L., Slater C.L., Tiao J.R., Baldwin M.R., Barr R.G., Chang B.P., Chau K.H., Choi J.J., Gavin N., et al. Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: Retrospective case series. BMJ. 2020;369:m1996. doi: 10.1136/bmj.m1996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1996</ArticleId><ArticleId IdType="pmc">PMC7256651</ArticleId><ArticleId IdType="pubmed">32471884</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T., Wu D., Chen H., Yan W., Yang D., Chen G., Ma K., Xu D., Yu H., Wang H., et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: Retrospective study. BMJ. 2020;26:m1091. doi: 10.1136/bmj.m1091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1091</ArticleId><ArticleId IdType="pmc">PMC7190011</ArticleId><ArticleId IdType="pubmed">32217556</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y.H., Zhao L., Yang X.C., Wang P. Cardiovascular complications of SARS-CoV-2 infection (COVID-19): A systematic review and meta-analysis. Rev. Cardiovasc. Med. 2021;22:159&#x2013;165. doi: 10.31083/j.rcm.2021.01.238.</Citation><ArticleIdList><ArticleId IdType="doi">10.31083/j.rcm.2021.01.238</ArticleId><ArticleId IdType="pubmed">33792257</ArticleId></ArticleIdList></Reference><Reference><Citation>Roh J.D., Kitchen R.R., Guseh J.S., McNeill J.N., Aid M., Martinot A.J., Yu A., Platt C., Rhee J., Weber B., et al. Plasma Proteomics of COVID-19&#x2013;Associated Cardiovascular Complications. JACC Basic Transl. Sci. 2022;7:425&#x2013;441. doi: 10.1016/j.jacbts.2022.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacbts.2022.01.013</ArticleId><ArticleId IdType="pmc">PMC9067411</ArticleId><ArticleId IdType="pubmed">35530264</ArticleId></ArticleIdList></Reference><Reference><Citation>Lala A., Johnson K.W., Januzzi J.L., Russak A.J., Paranjpe I., Richter F., Zhao S., Somani S., Van Vleck T., Vaid A., et al. Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection. J. Am. Coll. Cardiol. 2020;76:533&#x2013;546. doi: 10.1016/j.jacc.2020.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.06.007</ArticleId><ArticleId IdType="pmc">PMC7279721</ArticleId><ArticleId IdType="pubmed">32517963</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Coronavirus Disease (COVID-19) Dashboard [Internet]  [(accessed on 13 June 2023)].  Available online:  https://covid19.who.int/</Citation></Reference><Reference><Citation>Bilaloglu S., Aphinyanaphongs Y., Jones S., Iturrate E., Hochman J., Berger J.S. Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System. JAMA. 2020;324:799. doi: 10.1001/jama.2020.13372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.13372</ArticleId><ArticleId IdType="pmc">PMC7372509</ArticleId><ArticleId IdType="pubmed">32702090</ArticleId></ArticleIdList></Reference><Reference><Citation>McKee C.M., Coll R.C. NLRP3 inflammasome priming: A riddle wrapped in a mystery inside an enigma. J. Leukoc. Biol. 2020;108:937&#x2013;952. doi: 10.1002/JLB.3MR0720-513R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.3MR0720-513R</ArticleId><ArticleId IdType="pubmed">32745339</ArticleId></ArticleIdList></Reference><Reference><Citation>Magadum A., Kishore R. Cardiovascular Manifestations of COVID-19 Infection. Cells. 2020;9:2508. doi: 10.3390/cells9112508.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9112508</ArticleId><ArticleId IdType="pmc">PMC7699571</ArticleId><ArticleId IdType="pubmed">33228225</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqubal A., Iqubal M.K., Hoda F., Najmi A.K., Haque S.E. COVID-19 and cardiovascular complications: An update from the underlying mechanism to consequences and possible clinical intervention. Expert Rev. Anti-Infect. Ther. 2021;19:1083&#x2013;1092. doi: 10.1080/14787210.2021.1893692.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14787210.2021.1893692</ArticleId><ArticleId IdType="pmc">PMC7938651</ArticleId><ArticleId IdType="pubmed">33618607</ArticleId></ArticleIdList></Reference><Reference><Citation>Mullard A. NLRP3 inhibitors stoke anti-inflammatory ambitions. Nat. Rev. Drug Discov. 2019;18:405&#x2013;407. doi: 10.1038/d41573-019-00086-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41573-019-00086-9</ArticleId><ArticleId IdType="pubmed">31160775</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaccone G., Tomasoni D., Italia L., Lombardi C.M., Metra M. Myocardial Involvement in COVID-19: An Interaction Between Comorbidities and Heart Failure with Preserved Ejection Fraction. A Further Indication of the Role of Inflammation. Curr. Heart Fail. Rep. 2021;18:99&#x2013;106. doi: 10.1007/s11897-021-00509-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11897-021-00509-y</ArticleId><ArticleId IdType="pmc">PMC8062114</ArticleId><ArticleId IdType="pubmed">33890193</ArticleId></ArticleIdList></Reference><Reference><Citation>Ercegovac M., Asanin M., Savic-Radojevic A., Ranin J., Matic M., Djukic T., Coric V., Jerotic D., Todorovic N., Milosevic I., et al. Antioxidant Genetic Profile Modifies Probability of Developing Neurological Sequelae in Long-COVID. Antioxidants. 2022;11:954. doi: 10.3390/antiox11050954.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox11050954</ArticleId><ArticleId IdType="pmc">PMC9138155</ArticleId><ArticleId IdType="pubmed">35624818</ArticleId></ArticleIdList></Reference><Reference><Citation>Marzec J.M., Christie J.D., Reddy S.P., Jedlicka A.E., Vuong H., Lanken P.N., Aplenc R., Yamamoto T., Yamamoto M., Cho H.-Y., et al. Functional polymorphisms in the transcription factor NRF2 in humans increase the risk of acute lung injury. FASEB J. 2007;21:2237&#x2013;2246. doi: 10.1096/fj.06-7759com.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.06-7759com</ArticleId><ArticleId IdType="pubmed">17384144</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutton A., Khoury H., Prip-Buus C., Cepanec C., Pessayre D., Degoul F. The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria. Pharmacogenetics. 2003;13:145&#x2013;157. doi: 10.1097/00008571-200303000-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00008571-200303000-00004</ArticleId><ArticleId IdType="pubmed">12618592</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutton A., Imbert A., Igoudjil A., Descatoire V., Cazanave S., Pessayre D., Degoul F. The manganese superoxide dismutase Ala16Val dimorphism modulates both mitochondrial import and mRNA stability. Pharm. Genom. 2005;15:311&#x2013;319. doi: 10.1097/01213011-200505000-00006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01213011-200505000-00006</ArticleId><ArticleId IdType="pubmed">15864132</ArticleId></ArticleIdList></Reference><Reference><Citation>Crawford A., Fassett R.G., Geraghty D.P., Kunde D.A., Ball M.J., Robertson I.K., Coombes J.S. Relationships between single nucleotide polymorphisms of antioxidant enzymes and disease. Gene. 2012;501:89&#x2013;103. doi: 10.1016/j.gene.2012.04.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2012.04.011</ArticleId><ArticleId IdType="pubmed">22525041</ArticleId></ArticleIdList></Reference><Reference><Citation>Voetsch B., Jin R.C., Bierl C., Benke K.S., Kenet G., Simioni P., Ottaviano F., Damasceno B.P., Annichino-Bizacchi J.M., Handy D.E., et al. Promoter Polymorphisms in the Plasma Glutathione Peroxidase (GPx-3) Gene: A Novel Risk Factor for Arterial Ischemic Stroke Among Young Adults and Children. Stroke. 2007;38:41&#x2013;49. doi: 10.1161/01.STR.0000252027.53766.2b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.STR.0000252027.53766.2b</ArticleId><ArticleId IdType="pmc">PMC1781064</ArticleId><ArticleId IdType="pubmed">17122425</ArticleId></ArticleIdList></Reference><Reference><Citation>Jerotic D., Ranin J., Bukumiric Z., Djukic T., Coric V., Savic-Radojevic A., Todorovic N., Asanin M., Ercegovac M., Milosevic I., et al. SOD2 rs4880 and GPX1 rs1050450 polymorphisms do not confer risk of COVID-19, but influence inflammation or coagulation parameters in Serbian cohort. Redox Rep. 2022;27:85&#x2013;91. doi: 10.1080/13510002.2022.2057707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13510002.2022.2057707</ArticleId><ArticleId IdType="pmc">PMC8979533</ArticleId><ArticleId IdType="pubmed">35361071</ArticleId></ArticleIdList></Reference><Reference><Citation>Luchian M.L., Motoc A., Lochy S., Magne J., Belsack D., De Mey J., Roosens B., Van den Bussche K., Boeckstaens S., Chameleva H., et al. Subclinical Myocardial Dysfunction in Patients with Persistent Dyspnea One Year after COVID-19. Diagnostics. 2021;12:57. doi: 10.3390/diagnostics12010057.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics12010057</ArticleId><ArticleId IdType="pmc">PMC8775030</ArticleId><ArticleId IdType="pubmed">35054224</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Xu E., Benjamin B., Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat. Med. 2022;28:583&#x2013;590. doi: 10.1038/s41591-022-01689-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Crudo V.L., Ahmed A.I., Cowan E.L., Shah D.J., Al-Mallah M.H., Malahfji M. Acute and Subclinical Myocardial Injury in COVID-19. Methodist DeBakey Cardiovasc. J. 2021;217:22&#x2013;30. doi: 10.14797/mdcvj.1038.</Citation><ArticleIdList><ArticleId IdType="doi">10.14797/mdcvj.1038</ArticleId><ArticleId IdType="pmc">PMC8680173</ArticleId><ArticleId IdType="pubmed">34992721</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna H., Ryu A.J., Scott C.G., Mandale D.R., Naqvi T.Z., Pellikka P.A. Cardiac Abnormalities in COVID-19 and Relationship to Outcome. Mayo Clin. Proc. 2021;96:932&#x2013;942. doi: 10.1016/j.mayocp.2021.01.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.01.006</ArticleId><ArticleId IdType="pmc">PMC7816643</ArticleId><ArticleId IdType="pubmed">33714597</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman I. Antioxidant therapeutic advances in COPD. Ther. Adv. Respir. Dis. 2008;2:351&#x2013;374. doi: 10.1177/1753465808098224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1753465808098224</ArticleId><ArticleId IdType="pmc">PMC2744584</ArticleId><ArticleId IdType="pubmed">19124382</ArticleId></ArticleIdList></Reference><Reference><Citation>Montano M.A.E., da Cruz I., Duarte M.M.M.F., Krewer C.D.C., Rocha M.I.D.U.M.D., M&#xe2;nica-Cattani M.F., Soares F., Rosa G., Maris A.F., Battiston F.G., et al. Inflammatory cytokines in vitro production are associated with Ala16Val superoxide dismutase gene polymorphism of peripheral blood mononuclear cells. Cytokine. 2012;60:30&#x2013;33. doi: 10.1016/j.cyto.2012.05.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2012.05.022</ArticleId><ArticleId IdType="pubmed">22688013</ArticleId></ArticleIdList></Reference><Reference><Citation>Duarte T., da Cruz I.B.M., Barbisan F., Capelleto D., Moresco R.N., Duarte M.M.M.F. The effects of rosuvastatin on lipid-lowering, inflammatory, antioxidant and fibrinolytics blood biomarkers are influenced by Val16Ala superoxide dismutase manganese-dependent gene polymorphism. Pharm. J. 2016;16:501&#x2013;506. doi: 10.1038/tpj.2015.91.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/tpj.2015.91</ArticleId><ArticleId IdType="pubmed">26882122</ArticleId></ArticleIdList></Reference><Reference><Citation>Shuvalova Y.A., Kaminnyi A.I., Meshkov A.N., Shirokov R.O., Samko A.N. Association between polymorphisms of eNOS and GPx-1 genes, activity of free-radical processes and in-stent restenosis. Mol. Cell Biochem. 2012;370:241&#x2013;249. doi: 10.1007/s11010-012-1419-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11010-012-1419-3</ArticleId><ArticleId IdType="pubmed">22890915</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlsson J.O.G., Jynge P., Ignarro L.J. May Mangafodipir or Other SOD Mimetics Contribute to Better Care in COVID-19 Patients? Antioxidants. 2020;9:971. doi: 10.3390/antiox9100971.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox9100971</ArticleId><ArticleId IdType="pmc">PMC7601469</ArticleId><ArticleId IdType="pubmed">33050459</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S., Lee E.-K., Kang D.H., Lee J., Hong S.H., Jeong W., Kang S.W. Glutathione peroxidase-1 regulates ASK1-dependent apoptosis via interaction with TRAF2 in RIPK3-negative cancer cells. Exp. Mol. Med. 2021;53:1080&#x2013;1091. doi: 10.1038/s12276-021-00642-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-021-00642-7</ArticleId><ArticleId IdType="pmc">PMC8257591</ArticleId><ArticleId IdType="pubmed">34158609</ArticleId></ArticleIdList></Reference><Reference><Citation>Baroncini L.A.V., Borges L.J.L., Camarozano A.C., De Carmo D.C., Darwich R.Z., Fortunato Junior J.A. Echocardiographic Correlation between Right Ventricular Function and Left Atrial Volume. Arquivos Brasileiros de Cardiologia [Internet] 2019.  [(accessed on 13 June 2023)].  [cited 11 July 2022] Available online:  https://www.scielo.br/scielo.php?script=sci_arttext&amp;pid=S0066-782X2019000300249.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6424030</ArticleId><ArticleId IdType="pubmed">30916187</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood G., Kirkevang T.S., Agergaard J., Leth S., Hansen E.S.S., Laustsen C., Larsen A.H., Jensen H.K., &#xd8;stergaard L.J., B&#xf8;tker H.E., et al. Cardiac Performance and Cardiopulmonary Fitness After Infection With SARS-CoV-2. Front. Cardiovasc. Med. 2022;9:871603. doi: 10.3389/fcvm.2022.871603.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.871603</ArticleId><ArticleId IdType="pmc">PMC9136046</ArticleId><ArticleId IdType="pubmed">35647079</ArticleId></ArticleIdList></Reference><Reference><Citation>Muhammad Y., Kani Y.A., Iliya S., Muhammad J.B., Binji A., Ahmad A.E.-F., Kabir M.B., Bindawa K.U., Ahmed A. Deficiency of antioxidants and increased oxidative stress in COVID-19 patients: A cross-sectional comparative study in Jigawa, Northwestern Nigeria. SAGE Open Med. 2021;9:205031212199124. doi: 10.1177/2050312121991246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2050312121991246</ArticleId><ArticleId IdType="pmc">PMC7871282</ArticleId><ArticleId IdType="pubmed">33614035</ArticleId></ArticleIdList></Reference><Reference><Citation>Seale L.A., Torres D.J., Berry M.J., Pitts M.W. A role for selenium-dependent GPX1 in SARS-CoV-2 virulence. Am. J. Clin. Nutr. 2020;112:447&#x2013;448. doi: 10.1093/ajcn/nqaa177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/nqaa177</ArticleId><ArticleId IdType="pmc">PMC7337667</ArticleId><ArticleId IdType="pubmed">32592394</ArticleId></ArticleIdList></Reference><Reference><Citation>Anttila S., Hirvonen A., Vainio H., Husgafvel-Pursiainen K., Hayes J.D., Ketterer B. Immunohistochemical localization of glutathione S-transferases in human lung. Cancer Res. 1993;53:5643&#x2013;5648.</Citation><ArticleIdList><ArticleId IdType="pubmed">8242618</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowe J.D., Nieves E., Listowsky I. Subunit diversity and tissue distribution of human glutathione S-transferases: Interpretations based on electrospray ionization-MS and peptide sequence-specific antisera. Pt 2Biochem. J. 1997;325:481&#x2013;486. doi: 10.1042/bj3250481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bj3250481</ArticleId><ArticleId IdType="pmc">PMC1218585</ArticleId><ArticleId IdType="pubmed">9230131</ArticleId></ArticleIdList></Reference><Reference><Citation>Saha S., Buttari B., Panieri E., Profumo E., Saso L. An Overview of Nrf2 Signaling Pathway and Its Role in Inflammation. Molecules. 2020;25:5474. doi: 10.3390/molecules25225474.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules25225474</ArticleId><ArticleId IdType="pmc">PMC7700122</ArticleId><ArticleId IdType="pubmed">33238435</ArticleId></ArticleIdList></Reference><Reference><Citation>Thimmulappa R.K., Mai K.H., Srisuma S., Kensler T.W., Yamamoto M., Biswal S. Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res. 2002;62:5196&#x2013;5203.</Citation><ArticleIdList><ArticleId IdType="pubmed">12234984</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang R.M., Badano L.P., Mor-Avi V., Afilalo J., Armstrong A., Ernande L., Flachskampf F.A., Foster E., Goldstein S.A., Kuznetsova T., et al. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J. Am. Soc. Echocardiogr. 2015;28:1&#x2013;39.e14. doi: 10.1016/j.echo.2014.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2014.10.003</ArticleId><ArticleId IdType="pubmed">25559473</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagueh S.F., Smiseth O.A., Appleton C.P., Byrd B.F., 3rd, Dokainish H., Edvardsen T., Flachskampf F.A., Gillebert T.C., Klein A.L., Lancellotti P., et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J. Am. Soc. Echocardiogr. 2016;29:277&#x2013;314. doi: 10.1016/j.echo.2016.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2016.01.011</ArticleId><ArticleId IdType="pubmed">27037982</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang R.M., Badano L.P., Mor-Avi V., Afilalo J., Armstrong A., Ernande L., Flachskampf F.A., Foster E., Goldstein S.A., Kuznetsova T., et al. Multimodality imaging in patients with heart failure and preserved ejection fraction: An expert consensus document of the European Association of Cardiovascular Imaging. Eur. Heart J. Cardiovasc. Imaging. 2022;23:e34&#x2013;e61.</Citation><ArticleIdList><ArticleId IdType="pubmed">34729586</ArticleId></ArticleIdList></Reference><Reference><Citation>Voigt J.U., M&#x103;l&#x103;escu G.G., Haugaa K., Badano L. How to do LA strain. Eur. Heart J. Cardiovasc. Imaging. 2020;21:715&#x2013;717. doi: 10.1093/ehjci/jeaa091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jeaa091</ArticleId><ArticleId IdType="pubmed">32548623</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann V.O., Carerj M.L., Wieters I., Fahim M., Arendt C., Hoffmann J., Shchendrygina A., Escher F., Vasa-Nicotera M., Zeiher A.M., et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19) JAMA Cardiol. 2020;5:1265. doi: 10.1001/jamacardio.2020.3557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B.-H., Shi N.-N., Wu C.-W., An D.-A., Shi Y.-X., Wesemann L.D., Hu J., Xu J.-R., Shan F., Wu L.-M. Early cardiac involvement in patients with acute COVID-19 infection identified by multiparametric cardiovascular magnetic resonance imaging. Eur. Heart J.&#x2014;Cardiovasc. Imaging. 2021;22:844&#x2013;851. doi: 10.1093/ehjci/jeab042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jeab042</ArticleId><ArticleId IdType="pmc">PMC7989521</ArticleId><ArticleId IdType="pubmed">33686389</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotecha T., Knight D.S., Razvi Y., Kumar K., Vimalesvaran K., Thornton G., Patel R., Chacko L., Brown J.T., Coyle C., et al. Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance. Eur. Heart J. 2021;42:1866&#x2013;1878. doi: 10.1093/eurheartj/ehab075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab075</ArticleId><ArticleId IdType="pmc">PMC7928984</ArticleId><ArticleId IdType="pubmed">33596594</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>